By |

Profile

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. It develops a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted, prevascularized and scalable medical device.

Contact Information

Website: www.sernova.com
Email: info@sernova.com
Main Phone: +1 519 858-5184
Address: 700 Collip Circle, The Stiller Centre
Address 2: Suite 114
State: ON
City / Town: London
Country: CAN
Postal Code: N6G 4X8

Issuer Information

Exchange: CDX
CEO: Philip M. Toleikis
Employees: 9
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)


Gathering Data... Please wait

Profile

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. It develops a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted, prevascularized and scalable medical device.

Contact Information

Website: www.sernova.com
Email: info@sernova.com
Main Phone: +1 519 858-5184
Address: 700 Collip Circle, The Stiller Centre
Address 2: Suite 114
State: ON
City / Town: London
Country: CAN
Postal Code: N6G 4X8

Issuer Information

Exchange: CDX
CEO: Philip M. Toleikis
Employees: 9
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.76 0.76 0.76 0.76
Low Target Price Estimate 0.76 0.76 0.76 0.76
Mean Target Price Estimate 0.76 0.76 0.76 0.76
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 10/05/15 10/05/15 10/05/15 10/05/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago